「The BDC is another key building block supporting the company』s long-term strategy for increasing the pipeline』s share of biologicals. This is particularly driven by two of our core areas, immune…
Boehringer Ingelheim bolsters biologics research and development with 230 million euro investment in new development center
「The BDC is another key building block supporting the company』s long-term strategy for increasing the pipeline』s share of biologicals. This is particularly driven by two of our core areas, immune…